Carlsmed is a San Diego-based medical technology company that specializes in spine surgery. Their proprietary aprevo™ implant system, the first-ever surgical implant designated as a breakthrough technology by the FDA, offers personalized medicine benefits in lumbar fusion surgery. By leveraging machine learning and prior outcomes data, Carlsmed aims to improve surgical treatment for patients with adult spinal malalignment. Their FDA-cleared aprevo® devices, which have also received FDA Breakthrough Designation, are designed to enhance the standard of care by creating optimal surgical plans and personalized spine fusion devices for each patient.